Advanced Therapies Week 2026
CaseBioscience is advancing cryopreservation for cell therapy by going beyond viability. At ATW 2026, we are launching CaseCryo® CTG DMSO, the clinical version of CaseCryo® DMSO, designed to support cell therapy development and manufacturing, including use in clinical programs. Built on the precision and process discipline long established in assisted reproductive technology (ART), our approach applies a systems-level view of cryopreservation—where formulation, handling, and workflow are treated as one integrated solution. The result is cryopreservation designed not just to preserve cells, but to protect function, consistency, and performance across the full cell therapy lifecycle. Visit us at Booth 313 to learn more and connect with the CaseBioscience team at ATW 2026!
